Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Tropical Medicine and Infectious Disease|June 27, 2023
Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin LymphomaTommaso Lupia, Elena Crisà, Alberto Gaviraghi, et al.
Cancers|September 13, 2025
Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic NeoplasmElena Crisà, Irene Dogliotti, Giuseppe Lia, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2015
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic LeukemiaLuisa Giaccone, Ernesta Audisio, Benedetto Bruno, et al.
Leukemia|February 19, 2020
Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7Elena Crisà, Austin G Kulasekararaj, Vera Adema, et al.
Leukemia Research|June 28, 2011
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinibRoberto Latagliata, Massimo Breccia, Fausto Castagnetti, et al.
The Lancet. Haematology|May 1, 2019
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based studyAytug Kizilors, Elena Crisà, Nicholas Lea, et al.
Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
Cancer|March 19, 2021
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practiceMarino Clavio, Elena Crisà, Maurizio Miglino, et al.
British Journal of Haematology|February 9, 2022
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL studyElena Maria Elli, Ambra Di Veroli, Daniela Bartoletti, et al.
Cancer Medicine|October 29, 2019
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysisEnrico Balleari, Rosa Angela Filiberti, Chiara Salvetti, et al.
Pageof 5